Cannabis-based medicinal products

Page last updated: 8 July 2026

Remote online prescribing of cannabis-based medicinal products

If we cannot be assured that the arrangements promote safe prescribing or we have evidence that remote consultations are not being carried out safely, we may take regulatory action.

For example, we could impose conditions on your registration to prevent you from prescribing cannabis-based medicinal products remotely.

See our assessment framework for how we assess safe use of medicines.